photo
Speaker

Max Cynader

CEO, PRIMARY PEPTIDES INC
Vancouver, British Columbia, Canada
Professor of Ophthalmology at the University of British Columbia (UBC) and Canada Research Chair in Brain Development, Fellow of the Canadian Academy of Health Sciences, Fellow of the Royal Society of Canada, Founder of 4 start-ups. First company NeuroVir, a biotechnology company which developed gene therapy products to treat brain cancer, was sold for $140 million to Medigene AG in Germany in 2001
Speaking In
[Available On-Demand]
Primary Peptides Inc is a clinical-stage biotech company based in Vancouver, Canada. We are…